PharmaShots | Incisive News in 3 Shots

Subscribe Now

Arrowhead

Arrowhead & Sarepta Sign a Global Licensing and Collaboration Agreement for Multiple Clinical and Preclinical Programs

Arrowhead & Sarepta Sign a Global Licensing and Collaboration Agreement for Multiple Clinical and Preclinical Programs

November 27, 2024

Arrowhead Presents New P-II (ARCHES-2) Findings for Zodasiran at AHA 2023

Arrowhead Presents New P-II (ARCHES-2) Findings for Zodasiran at AHA 2023

November 14, 2023

Arrowhead Published New Findings from 2 P-II (SHASTA-2 & MUIR) studies for Plozasiran at AHA 2023

Arrowhead Published New Findings from 2 P-II (SHASTA-2 & MUIR) studies for Plozasiran at AHA 2023

November 14, 2023

Arrowhead and Janssen Entered into a Licensing Agreement with GSK for JNJ-3989 to Treat Chronic Hepatitis B

Arrowhead and Janssen Entered into a Licensing Agreement with GSK for JNJ-3989 to Treat Chronic Hepatitis B

November 1, 2023

Arrowhead Reports the First Patient Dosing of Fazirsiran in the P-III Trial (REDWOOD) for Alpha-1 Antitrypsin Deficiency Associated Liver Disease

Arrowhead Reports the First Patient Dosing of Fazirsiran in the P-III Trial (REDWOOD) for Alpha-1 Antitrypsin Deficiency Associate...

April 5, 2023

Arrowhead Gains Full Rights to ARO-PNPLA3 for Patients with Non-Alcoholic Steatohepatitis

Arrowhead Gains Full Rights to ARO-PNPLA3 for Patients with Non-Alcoholic Steatohepatitis

February 16, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us